Your SlideShare is downloading. ×
Bacterial Diarrhea
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Bacterial Diarrhea

2,943

Published on

Bacterial Diarrhea …

Bacterial Diarrhea
N Engl J Med 2009;361:1560-9.

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,943
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
146
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. CLINICAL PRACTICE
    Bacterial Diarrhea
    N Engl J Med2009;361:1560-9.
  • 2. Clinical Problem
    More than 5.2 million cases of bacterial diarrhea that occur each year in the US, estimated 46,000 hospitalizations and 1,500 deaths each year in US.
    The 4 most commonly reported bacterial enteropathogens in the US:
    Campylobacter
    Salmonella
    Shiga toxin-producing E. Coli
    Shigell
  • 3.
  • 4.
  • 5. Evaluation
    Stool culture should be obtained from all patients with
    severe diarrhea (passage > 6 unformed stools per day)
    diarrhea of any severity that persists for longer than a week
    fever
    dysentery
    multiple cases of illness that suggest an outbreak
    Stool cultures are not routine in most cases of watery diarrhea or traveler’s diarrhea because of the low yield of bacterial pathogens.
  • 6. Conditions Associated with Bacterial Diarrhea
    Acute Watery Diarrhea
    Dysentery
    Food Poisoning
    Traveler’s Diarrhea
    Nosocomial Diarrhea
  • 7. Acute Watery Diarrhea
    Clinically nonspecific!
    Most bacterial and nonbacterial enteropathogens produce acute watery diarrhea
    Detectable enteric pathogens is identified in fewer than 3% of cases in the US.
    Most laboratories stool culture are set up to routinely look for shigella, salmonella, and campylobacter.
    Many of the potentially important agents that cause watery diarrhea are not detectable by routine laboratory tests;
    these agents include entero-toxigenicE. coli, entero-aggregative E. coli, entero-invasive E. coli, non-choleraicvibrios, and noroviruses.
  • 8. Dysentery
    Passage of bloody stools suggests possible bacterial colitis.
    Major causes of bloody diarrhea in the US:
    Shigella
    Campylobacter
    Salmonella
    Shiga toxin-producing E. coli
    Severe abdominal pain and cramps and passage > 5 unformed stools per 24 hours in the absence of fever
    Watery diarrhea becomes bloody in 1 to 5 days in 80% of patients
    Shiga toxin-producing E. coli is the main cause of renal failure in childhood
    2/3 of children with the hemolytic-uremic syndrome require dialysis; mortality rate: 3 to 5%
  • 9. Food Poisoning
    Food poisoning is the term used when a preformed toxin in food is ingested, resulting in an intoxication rather than an enteric infection.
    Staphylococcus aureus causes vomiting within 2 to 7 hours after the ingestion of improperly cooked or stored food containing a heat-stable preformed toxin.
    Most cases of food poisoning are of short duration, with recovery occurring in 1 to 2 days. The diagnosis is made in nearly all cases clinically without laboratory confirmation.
  • 10. Traveler’s Diarrhea
    Traveler’s diarrhea occurs when persons from industrialized regions venture into developing tropical and semitropical areas with reduced levels of personal and food hygiene.
    Bacterial enteropathogens cause up to 80% of cases.
    E. coli account for more than half of cases occurring in Latin America, Africa, and South Asia.
    Campylobacter, shigella, and salmonella are relatively more important causes of traveler’s diarrhea in Asia than in the other high-risk regions.
  • 11. Traveler’s Diarrhea
    Patients with traveler’s diarrhea should be treated empirically with antibiotics without stool examination.
    Most authorities recommend rifaximin 200 mg once or twice a day (with major meals) while the person is in an area of risk.
    Alternative regimen is two tablets of bismuth subsalicylate with each meal and at bedtime.
    Indications for the use of chemoprophylaxis
    important trip
    (the purpose of which might be ruined by a short-term illness)
    underlying illness that might be worsened by diarrhea (e.g., CHF)
    persons more susceptible to diarrhea (e.g., use of daily PPI therapy)
    previous bouts of traveler’s diarrhea
  • 12. Nosocomial Diarrhea
    C. difficile accounts for a minority of antibiotic-associated and hospital-associated diarrhea, it should be considered in patients with clinically significant diarrhea (passage > 3 unformed stools per day), toxic dilatation of the colon or otherwise unexplained leukocytosis, or both.
    Risk factors for C. difficile diarrhea:
    Advanced age and coexisting conditions
    alteration of intestinal flora by antimicrobial agents
    probably host genetics
  • 13.
  • 14. Treatment
    Fluid and electrolyte replacement
    Easily digestible food
    Antimotility drugs such as loperamide and diphenoxylate hydrochloride
    Antimicrobial agents
  • 15. Salmonellosis
    Bacteremia complicates the infection in approximately 8% of normal healthy persons.
    Risk factors:
    Extremes of age (younger than 3 months and 65 years or older)
    corticosteroid use
    Inflammatory bowel disease
    immunosuppression
    Hemoglobinopathy including sickle cell disease
    hemodialysis
  • 16. Shiga toxin-roducingE. coli
    Some antibacterial drugs, including fluoroquinolones and trimethoprim-sulfamethoxazole, may increase the risk of hemolytic–uremic syndrome.
    Most authorities recommend supportive treatment only in patients with Shiga toxin-producing E. coli infection.

×